Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder
Titel:
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder
Auteur:
Bhattacharyya, Sudeepa MahmoudianDehkordi, Siamak Sniatynski, Matthew J. Belenky, Marina Marur, Vasant R. Rush, A. John Craighead, W. Edward Mayberg, Helen S. Dunlop, Boadie W. Kristal, Bruce S. Kaddurah-Daouk, Rima